Filing Details
- Accession Number:
- 0001213900-18-011213
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-15 17:07:13
- Reporting Period:
- 2018-08-13
- Accepted Time:
- 2018-08-15 17:07:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1506251 | Citius Pharmaceuticals Inc. | CTXR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1463414 | L Leonard Mazur | C/O Citius Pharmaceuticals, Inc. 11 Commerce Drive, 1St Floor Cranford NJ 07016 | Executive Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-13 | 3,137,255 | $1.28 | 6,855,595 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2018-08-13 | 3,137,255 | $0.00 | 3,137,255 | $1.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,137,255 | 2023-08-14 | No | 4 | A | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Options to Purchase Common Stock | $3.45 | 2027-09-13 | 40,000 | 40,000 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $6.15 | 2019-06-12 | 19,614 | 19,614 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $9.90 | 2019-09-30 | 3,171 | 3,171 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $9.90 | 2020-01-08 | 4,984 | 4,984 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $7.50 | 2020-08-18 | 35,211 | 35,211 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $7.50 | 2020-11-02 | 20,783 | 20,783 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $7.50 | 2020-11-20 | 20,664 | 20,664 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $7.50 | 2021-01-08 | 13,679 | 13,679 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $7.50 | 2021-03-14 | 4,210 | 4,210 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $6.15 | 2021-03-15 | 18,106 | 18,106 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $4.13 | 2022-08-08 | 421,400 | 421,400 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $4.13 | 2022-08-08 | 11,000 | 11,000 | Direct | |
Common Stock | Options to Purchase Common Stock | $6.75 | 2024-09-12 | 220,000 | 220,000 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $4.63 | 2023-06-19 | 106,553 | 106,553 | Direct | |
Common Stock | Warrant to Purchase Common Stock | $2.86 | 2023-09-29 | 167,504 | 167,504 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-09-13 | 40,000 | 40,000 | Direct |
2019-06-12 | 19,614 | 19,614 | Direct |
2019-09-30 | 3,171 | 3,171 | Direct |
2020-01-08 | 4,984 | 4,984 | Direct |
2020-08-18 | 35,211 | 35,211 | Direct |
2020-11-02 | 20,783 | 20,783 | Direct |
2020-11-20 | 20,664 | 20,664 | Direct |
2021-01-08 | 13,679 | 13,679 | Direct |
2021-03-14 | 4,210 | 4,210 | Direct |
2021-03-15 | 18,106 | 18,106 | Direct |
2022-08-08 | 421,400 | 421,400 | Direct |
2022-08-08 | 11,000 | 11,000 | Direct |
2024-09-12 | 220,000 | 220,000 | Direct |
2023-06-19 | 106,553 | 106,553 | Direct |
2023-09-29 | 167,504 | 167,504 | Direct |
Footnotes
- One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest, provided the Reporting Person continues to serve as a member of the Company's Board of Directors as of each such vesting date.
- The warrant is fully vested and exercisable immediately.
- The option vested as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017.
- The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.